Summary of Magellan Health, Inc. (NASDAQ:MGLN) Ratings

May 3, 2018 - By Sarah Holford

Magellan Health, Inc. (NASDAQ:MGLN) Corporate Logo
Big Money Sentiment increased to 1.45 in 2017 Q4. It has change of 0.47, from 2017Q3’s 0.98. The ratio increased due to Magellan Health, Inc. positioning: 12 sold and 64 reduced. 38 funds acquired stakes and 72 increased stakes. Investors holded 22.27 million in 2017Q3 but now own 22.62 million shares or 1.60% more.
Cubist Systematic Strategies Limited Com holds 0.04% or 8,472 shs. Sei Invests has 3,038 shs for 0% of their capital. Atlantic Grp Ltd Liability Corporation has invested 0% in Magellan Health, Inc. (NASDAQ:MGLN). Vident Advisory Ltd has invested 0.12% of its capital in Magellan Health, Inc. (NASDAQ:MGLN). 112,920 are owned by Invesco Limited. Bancorp Of America De owns 69,434 shs. Parametric Associate Ltd reported 0.02% in Magellan Health, Inc. (NASDAQ:MGLN). 12,778 were reported by Wellington Group Llp. Zacks Investment Mngmt reported 0.07% of its capital in Magellan Health, Inc. (NASDAQ:MGLN). Renaissance Limited Company has 1.04 million shs. Nuveen Asset Ltd Com has 0.01% invested in Magellan Health, Inc. (NASDAQ:MGLN). Boston Advsrs Ltd Llc invested 0.03% of its capital in Magellan Health, Inc. (NASDAQ:MGLN). Jpmorgan Chase & Co reported 690,936 shs or 0.01% of all its holdings. Legal And General Grp Incorporated Pcl invested in 70,240 shs or 0% of the stock. Eqis Incorporated reported 7,134 shs.

Magellan Health, Inc. registered $13.89 million net activity with 0 insider purchases and 9 insider sales since January 2, 2018. SMITH BARRY M sold $1.35 million worth of Magellan Health, Inc. (NASDAQ:MGLN) or 13,375 shs on Thursday, March 1. Kamal Mostafa had sold 1,666 shs worth $176,929. GREGOIRE DANIEL N also sold $2.27 million worth of Magellan Health, Inc. (NASDAQ:MGLN) on Monday, March 5.

Magellan Health, Inc. (NASDAQ:MGLN) Ratings Coverage

In total 4 analysts cover Magellan Health (NASDAQ:MGLN). “Buy” rating has 4, “Sell” are 0, while 0 are “Hold”. (NASDAQ:MGLN) has 100% bullish analysts. 7 are the (NASDAQ:MGLN)’s ratings reports on May 3, 2018 according to StockzIntelligence Inc. On Thursday, March 15 the firm earned “Buy” rating by Leerink Swann. On Friday, December 1 the firm has “Buy” rating given by KeyBanc Capital Markets. On Tuesday, May 1 the firm earned “Outperform” rating by Raymond James. The company rating was maintained by Jefferies on Friday, December 1. On Friday, April 27 the company was maintained by Leerink Swann. On Friday, March 23 the company was maintained by Jefferies. On Friday, December 1 the stock has “Hold” rating by Raymond James. Listed here are Magellan Health, Inc. (NASDAQ:MGLN) PTs and latest ratings.

01/05/2018 Broker: Raymond James Old Rating: Market Perform New Rating: Outperform Upgrade
27/04/2018 Broker: Leerink Swann Rating: Buy New Target: $100.0000 Maintain
23/03/2018 Broker: Jefferies Rating: Buy New Target: $120.0000 Maintain
15/03/2018 Broker: Leerink Swann Rating: Buy New Target: $120.0 Upgrade
01/12/2017 Broker: Jefferies Rating: Buy New Target: $110.0 Maintain
01/12/2017 Broker: Raymond James Rating: Hold Maintain
01/12/2017 Broker: KeyBanc Capital Markets Rating: Buy New Target: $105.0 Maintain

Ticker’s shares touched $85.9 during the last trading session after 3.43% change.Magellan Health, Inc. has volume of 84,323 shares. Since May 3, 2017 MGLN has risen 60.27% and is uptrending. MGLN outperformed by 48.72% the S&P 500.

Magellan Health, Inc. engages in the healthcare management business in the United States.The firm is worth $2.08 billion. The companyÂ’s Healthcare segment engages in the management of behavioral healthcare services and employee assistance program services; management of other specialty areas, including diagnostic imaging and musculoskeletal management; and the integrated management of physical, behavioral, and pharmaceutical healthcare for special populations comprising individuals with serious mental illness, dual eligibles, long-term services and supports, and other populations with unique and often complex healthcare needs.19.05 is the P/E ratio. This segment provides its healthcare services through its comprehensive network of medical and behavioral health professionals, clinics, hospitals, and ancillary service providers.

Magellan Health, Inc. (NASDAQ:MGLN) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: